Breast Biopsy Market Research Report: Information, By Product (Biopsy Needles, and Biopsy Tables), By technique type (Fine Needle Aspiration Biopsy, and Core Needle Biopsy), By Guidance Technology (Ultrasound-guided, and CT-guided), By End-User (Hospitals, and Labs), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Breast Biopsy Market, by Product

6.1 Introduction

6.2 Biopsy Needles

6.3 Biopsy Tables

6.4 Biopsy Wires

6.5 Guidance Systems

6.6 Others

Chapter 7. Global Breast Biopsy market, by Technique Type

7.1 Introduction

7.2 Fine Needle Aspiration Biopsy

7.3 Core Needle Biopsy

7.3.1 Stereotactic Core Needle Biopsy

7.3.2 Vacuum Assisted Biopsies

7.3.3 Ultrasound Guided Core Biopsy

7.3.4 Freehand Needle Biopsy

7.4 Biopsy Markers

7.5 MRI-Guided Core Needle Biopsy

7.6 Surgical Biopsy

7.6.1 Incisional Biopsy

7.6.2 Excisional Biopsy

7.7 Wire Localization

7.8 Sentinel Node Biopsy

Chapter 8. Global Breast Biopsy Market, by Guidance Technology

8.1 Introduction

8.2 Fine Ultrasound-Guided

8.3 Mammography-Guided magnetic resonance

8.4 CT-Guided Biopsy

8.5 Other Image-Guided Breast Biopsy (PET and thermography)

Chapter 9 Global Breast Biopsy Market, by End-User

9.1 Introduction

9.2 Hospitals

9.3 Ambulatory Surgical Centers

9.4 Diagnostic Centers

9.5 Other

Chapter 10. Global Breast Biopsy Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Becton, Dickinson and Company

12.1.1 Company Overview

12.1.2 Type Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 C.R. Bard, Inc.

12.2.1 Company Overview

12.2.2 Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Devicor Medical Products Inc.

12.3.1 Company Overview

12.3.2 Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Hologic Inc.

12.4.1 Company Overview

12.4.2 Type/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Argon Medical Devices

12.5.1 Company Overview

12.5.2 Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Cook Medical Incorporated

12.6.1 Company Overview

12.6.2 Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Encapsule Medical Devices LLC.

12.7.1 Overview

12.7.2 Type Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Johnson & Johnson

12.8.1 Overview

12.8.2 Type Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Galini SRL

12.9.1 Overview

12.9.2 Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Intact Medical Corporation

12.10.1 Overview

12.10.2 Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 CONCEPTUS INC

12.11.1 Overview

12.11.2 Type Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Hologic Inc.,

12.12.1 Overview

12.12.2 Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Karl Storz GmbH & Co. Kg

12.13.1 Overview

12.13.2 Type Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.14 GE Healthcare

12.14.1 Overview

12.14.2 Type Overview

12.14.3 Financials

12.14.4 Key Developments

12.14.5 SWOT Analysis

12.15 Others

Chapter 13 Appendix

LIST OF TABLES

Table 1 Breast Biopsy Market Industry Synopsis, 2018–2023

Table 2 Global Breast Biopsy Market Estimates & Forecast, 2018–2023, (USD Million)

Table 3 Global Breast Biopsy Market, by Region, 2018–2023, (USD Million)

Table 4 Global Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Table 5 Global Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 6 Global Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

Table 7 North America: Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Table 8 North America: Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 9 North America: Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

Table 10 US: Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Table 11 US: Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 12 US: Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

Table 13 Canada: Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Table 14 Canada: Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 15 Canada: Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

Table 16 South America: Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Table 17 South America: Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 18 South America: Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

Table 19 Europe: Breast Biopsy Market, Diagnosis, 2018–2023, (USD Million)

Table 20 Europe: Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 21 Europe: Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

Table 22 Western Europe: Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Table 23 Western Europe: Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 24 Western Europe: Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

Table 25 Eastern Europe: Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Table26 Eastern Europe: Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 27 Eastern Europe: Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

Table 28 Asia-Pacific Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Table 29 Asia-Pacific: Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 30 Asia-Pacific: Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

Table 31 Middle East & Africa: Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Table 32 Middle East & Africa: Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 33 Middle East & Africa: Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Breast Biopsy Market

Figure 3 Market Dynamics for Global Breast Biopsy Market

Figure 4 Global Breast Biopsy Market Share, by Diagnosis 2020

Figure 5 Global Breast Biopsy Market Share, by Treatment 2020

Figure 6 Global Breast Biopsy Market Share, by End-User, 2020

Figure 7 Global Breast Biopsy Market Share, by Region, 2020

Figure 8 North America: Breast Biopsy Market Share, by Country, 2020

Figure 9 Europe: Breast Biopsy Market Share, by Country, 2020

Figure 10 Asia-Pacific: Breast Biopsy Market Share, by Country, 2020

Figure 11 Middle East & Africa: Breast Biopsy Market Share, by Country, 2020

Figure 12 Global Breast Biopsy Market: Company Share Analysis, 2020 (%)

Figure 13 PFIZER INC: Key Financials

Figure 14 PFIZER INC: Segmental Revenue

Figure 15 PFIZER INC: Geographical Revenue

Figure 16 Koninklijke Philips N.V: Key Financials

Figure 17 Koninklijke Philips N.V: Segmental Revenue

Figure 18 Koninklijke Philips N.V: Geographical Revenue

Figure 19 Boston Scientific Corporation: Key Financials

Figure 20 Boston Scientific Corporation: Segmental Revenue

Figure 21 Boston Scientific Corporation: Geographical Revenue

Figure 22 LUPIN: Key Financials

Figure 23 LUPIN: Segmental Revenue

Figure 24 LUPIN: Geographical Revenue

Figure 25 Bayer AG: Key Financials

Figure 26 Bayer AG: Segmental Revenue

Figure 27 Bayer AG: Geographical Revenue

Figure 28 PHYTON: Key Financials

Figure 29 PHYTON: Segmental Revenue

Figure 30 PHYTON: Geographical Revenue

Figure 31 CELGENE CORPORATION. : Key Financials

Figure 32 CELGENE CORPORATION. : Segmental Revenue

Figure 33 CELGENE CORPORATION. : Geographical Revenue

Figure 34 Johnson & Johnson: Key Financials

Figure 35 Johnson & Johnson: Segmental Revenue

Figure 36 Johnson & Johnson: Geographical Revenue

Figure 37 CooperSurgical Inc.: Key Financials

Figure 38 CooperSurgical Inc.: Segmental Revenue

Figure 39 CooperSurgical Inc.: Geographical Revenue

Figure 40 LiNA Medical USA: Key Financials

Figure 41 LiNA Medical USA: Segmental Revenue

Figure 42 LiNA Medical USA: Geographical Revenue

Figure 46 Hologic Inc.: Key Financials

Figure 47 Hologic Inc.: Segmental Revenue

Figure 48 Hologic Inc.: Geographical Revenue

Figure 49 Karl Storz GmbH & Co. Kg: Key Financials

Figure 50 Karl Storz GmbH & Co. Kg: Segmental Revenue

Figure 51 Karl Storz GmbH & Co. Kg: Geographical Revenue

Figure 52 C.R. Bard: Key Financials

Figure 53 C.R. Bard: Segmental Revenue

Figure 54 C.R. Bard: Geographical Revenue

Figure 55 GE Healthcare: Key Financials

Figure 56 GE Healthcare: Segmental Revenue

Figure 57 GE Healthcare: Geographical Revenue